id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-265721-wmz3wywi	Saini, Kamal S.	Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy	2020-06-22		.txt	text/plain	1974	99	35	Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course of COVID-19. The pharmaceutical industry, contract research organisations (CROs), and academia have spent decades developing drugs for cancer-induced inflammation, immune dysfunction, and coagulopathy; given that this triad is also seen in patients affected by COVID-19, it is reasonable to consider testing selected anticancer agents in a rational manner against this viral illness.	./cache/cord-265721-wmz3wywi.txt	./txt/cord-265721-wmz3wywi.txt